(1S,4R)-tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

Catalog No. :
ACXOMG839
CAS No. :
163513-99-3
Molecular Formula :
C11H17NO3
Molecular Weight :
211.26

IUPAC Name:tert-butyl (1S,4R)-2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

(1S,4R)-tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$95.00Login to see priceIn stockInquiry
250mg97%$207.00Login to see priceIn stockInquiry
1g97%$816.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1S,4R)-tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate
IUPAC Nametert-butyl (1S,4R)-2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate
MDL No.MFCD22576207
Molecular FormulaC11H17NO3
Molecular Weight211.26
SMILESO=C(N1[C@]2([H])C(C[C@@]1([H])CC2)=O)OC(C)(C)C
InChI KeyXWIJVOQGKJHEAJ-SFYZADRCSA-N
Synonymtert-butyl (1S,4R)-2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate;(1S,4R)-tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate;7-Azabicyclo[2.2.1]heptane-7-carboxylic acid, 2-oxo-, 1,1-dimethylethyl ester, (1S,4R)-;(1S,4R)-7-Boc-7-azabicyclo[2.2.1]heptan-2-one
CAS No.163513-99-3
PubChem CID11790504

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACXOMG839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOMG839 route product structure diagram
    ACXOMG839163513-99-3 In Stock
Inquiry

2. ACXOMG839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOMG839 route product structure diagram
    ACXOMG839163513-99-3 In Stock
Inquiry

Comments (0)